FDA Inspection
Reproductive Medicine InstituteReproductive Medicine Institute – FDA Inspection, Jan 18, 2013
Record Details
This FDA Inspection record concerns Reproductive Medicine Institute, with an inspection on January 18, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 18, 2013
- Product Type
- Biologics
View Company Profile
ID · 13273626-c0ed-4cab-8034-6a5ada99c2db
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 814339
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.55(d)(2)Accurate, indelible, legible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reproductive Medicine Institute
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2026 | Not classified | Chicago District Office | |
| November 14, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Medicine Institute
- FDA Inspection 1306640 - 2026-03-09
- FDA Inspection 1073855 - 2018-11-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.